Report cover image

Drug of Abuse Testing Market Size, Share & Trends Analysis Report 2025-2033

Publisher Acumen Research and Consulting
Published Mar 01, 2025
Length 250 Pages
SKU # ACRC19876741

Description

The Global Drug of Abuse Testing Market Size accounted for USD 7.05 Billion in 2024 and is estimated to achieve a market size of USD 12.46 Billion by 2033 growing at a CAGR of 6.7% from 2025 to 2033.

The drug of abuse testing market refers to the industry involved in the detection of illicit drug use or abuse through various diagnostic tools and technologies. This market serves a wide range of applications, from law enforcement and workplace drug testing to clinical and rehabilitation settings. As the global prevalence of drug abuse continues to rise, the demand for accurate, rapid, and reliable drug testing solutions has surged. This abstract delves into the current trends, market drivers, key challenges, opportunities, and future projections within the drug of abuse testing industry.

Drug abuse is a growing concern worldwide, with rising rates of addiction to substances such as opioids, cocaine, cannabis, amphetamines, and prescription medications. The increase in drug-related deaths and the escalating societal burden of substance abuse are prompting governments, healthcare providers, employers, and law enforcement agencies to invest in effective drug testing methods. These tests play a crucial role in detecting illicit drug use, monitoring individuals in treatment programs, ensuring workplace safety, and preventing criminal activity related to drug consumption.

Drug of Abuse Testing Market Segmentation

The worldwide market for drug of abuse testing is split based on drug type, product, sample type, end-user, and geography.

Drug of Abuse Testing Market By Drug Type
Alcohol
LSD
Cocaine
Opioids
Marijuana/Cannabis
Amphetamine & Methamphetamine
Others

Drug of Abuse Testing Market By Product

Equipment
Immunoassay Analyzers
Breath Analyzers
Chromatography Instruments
Consumables
Reagents
Rapid Test Kits
Others

Drug of Abuse Testing Market By Sample Type

Urine
Breath
Saliva
Blood
Hair
Others

Drug of Abuse Testing End-user

Hospitals
Workplaces
Research Labs
Criminal Justice Systems

Drug of Abuse Testing Market Regional Outlook

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of LATAM
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Drug of Abuse Testing Market Players

Some of the top drug of abuse testing companies offered in our report includes DrugScan, Mayo Clinic Laboratories, Danaher Corporation, Precision Diagnostics, Cordant Health Solutions, LabCorp, Abbott Laboratories, Quest Diagnostics, Inc., LGC Group, and Legacy Medical Services.

Table of Contents

250 Pages
CHAPTER 1.Industry Overview of Drug of Abuse Testing Market
1.1.Definition and Scope
1.2.Summary
CHAPTER 2.Research Approach
2.1.Methodology
2.2.Data Source
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.2.Restraints and Challenges
3.3.Growth Opportunities
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Drug of Abuse Testing Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Drug of Abuse Testing Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2024
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2024
4.2.R&D Status of Major Manufacturers in 2024
CHAPTER 5.Drug of Abuse Testing Market By Drug Type
5.1.Introduction
5.2.Drug of Abuse Testing Revenue By Drug Type
5.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Drug Type, 2021-2033
5.2.2.Alcohol
5.2.2.1.Alcohol Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.3.LSD
5.2.3.1.LSD Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.4.Cocaine
5.2.4.1.Cocaine Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.5.Opioids
5.2.5.1.Opioids Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.6.Marijuana/Cannabis
5.2.6.1.Marijuana/Cannabis Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.7.Amphetamine & Methamphetamine
5.2.7.1.Amphetamine & Methamphetamine Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.8.Others
5.2.8.1.Others Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 6.Drug of Abuse Testing Market By Product
6.1.Introduction
6.2.Drug of Abuse Testing Revenue By Product
6.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Product, 2021-2033
6.2.2.Equipment
6.2.2.1.Equipment Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.2.2.Immunoassay Analyzers
6.2.2.2.1.Immunoassay Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.2.3.Breath Analyzers
6.2.2.3.1.Breath Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.2.4.Chromatography Instruments
6.2.2.4.1.Chromatography Instruments Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.3.Consumables
6.2.3.1.Consumables Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.3.2.Reagents
6.2.3.2.1.Reagents Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.3.3.Rapid Test Kits
6.2.3.3.1.Rapid Test Kits Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.3.4.Others
6.2.3.4.1.Others Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 7.Drug of Abuse Testing Market By Sample Type
7.1.Introduction
7.2.Drug of Abuse Testing Revenue By Sample Type
7.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Sample Type, 2021-2033
7.2.2.Urine
7.2.2.1.Urine Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.3.Breath
7.2.3.1.Breath Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.4.Saliva
7.2.4.1.Saliva Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.5.Blood
7.2.5.1.Blood Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.6.Hair
7.2.6.1.Hair Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.7.Others
7.2.7.1.Others Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 8.Drug of Abuse Testing Market By End-user
8.1.Introduction
8.2.Drug of Abuse Testing Revenue By End-user
8.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By End-user, 2021-2033
8.2.2.Hospitals
8.2.2.1.Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
8.2.3.Workplaces
8.2.3.1.Workplaces Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
8.2.4.Research Labs
8.2.4.1.Research Labs Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
8.2.5.Criminal Justice Systems
8.2.5.1.Criminal Justice Systems Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 9.North America Drug of Abuse Testing Market By Country
9.1.North America Drug of Abuse Testing Market Overview
9.2.U.S.
9.2.1.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
9.2.2.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
9.2.3.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
9.2.4.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End-Use, 2021-2033
9.3.Canada
9.3.1.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
9.3.2.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
9.3.3.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
9.3.4.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
9.4.North America PEST Analysis
CHAPTER 10.Europe Drug of Abuse Testing Market By Country
10.1.Europe Drug of Abuse Testing Market Overview
10.2.U.K.
10.2.1.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
10.2.2.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
10.2.3.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
10.2.4.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.3.Germany
10.3.1.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
10.3.2.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
10.3.3.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
10.3.4.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.4.France
10.4.1.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
10.4.2.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
10.4.3.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
10.4.4.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.5.Spain
10.5.1.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
10.5.2.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
10.5.3.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
10.5.4.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.6.Rest of Europe
10.6.1.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
10.6.2.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
10.6.3.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
10.6.4.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.7.Europe PEST Analysis
CHAPTER 11.Asia Pacific Drug of Abuse Testing Market By Country
11.1.Asia Pacific Drug of Abuse Testing Market Overview
11.2.China
11.2.1.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
11.2.2.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
11.2.3.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
11.2.4.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.3.Japan
11.3.1.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
11.3.2.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
11.3.3.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
11.3.4.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.4.India
11.4.1.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
11.4.2.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
11.4.3.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
11.4.4.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.5.Australia
11.5.1.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
11.5.2.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
11.5.3.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
11.5.4.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.6.South Korea
11.6.1.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
11.6.2.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
11.6.3.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
11.6.4.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.7.Rest of Asia-Pacific
11.7.1.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
11.7.2.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
11.7.3.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
11.7.4.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.8.Asia Pacific PEST Analysis
CHAPTER 12.Latin America Drug of Abuse Testing Market By Country
12.1.Latin America Drug of Abuse Testing Market Overview
12.2.Brazil
12.2.1.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
12.2.2.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
12.2.3.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
12.2.4.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
12.3.Mexico
12.3.1.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
12.3.2.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
12.3.3.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
12.3.4.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
12.4.Rest of Latin America
12.4.1.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
12.4.2.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
12.4.3.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
12.4.4.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
12.5.Latin America PEST Analysis
CHAPTER 13.Middle East & Africa Drug of Abuse Testing Market By Country
13.1.Middle East & Africa Drug of Abuse Testing Market Overview
13.2.GCC
13.2.1.GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
13.2.2.GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
13.2.3.Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
13.2.4.Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
13.3.South Africa
13.3.1.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
13.3.2.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
13.3.3.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
13.3.4.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
13.4.Rest of Middle East & Africa
13.4.1.Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033
13.4.2.Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033
13.4.3. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033
13.4.4.Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033
13.5.Middle East & Africa PEST Analysis
CHAPTER 14.Player Analysis Of Drug of Abuse Testing Market
14.1.Drug of Abuse Testing Market Company Share Analysis
14.2.Competition Matrix
14.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2.New Product Launches and Product Enhancements
14.2.3.Mergers And Acquisition In Global Drug of Abuse Testing Market
14.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15.Company Profile
15.1.DrugScan
15.1.1.Company Snapshot
15.1.2.Business Overview
15.1.3.Financial Overview
15.1.3.1.Revenue (USD Billion), 2024
15.1.3.2.DrugScan 2024 Drug of Abuse Testing Business Regional Distribution
15.1.4.Product /Service and Specification
15.1.5.Recent Developments & Business Strategy
15.2.Mayo Clinic Laboratories
15.3.Danaher Corporation
15.4.Precision Diagnostics
15.5.Cordant Health Solutions
15.6.LabCorp
15.7.Abbott Laboratories
15.8.Quest Diagnostics, Inc.
15.9.LGC Group
15.10.Legacy Medical Services

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us